Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Atopic Dermatitis”

444 trials

Showing 20 of 444 results

Large-scale testing (Phase 3)Study completedNCT03912259
What this trial is testing

Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Sanofi 165
Not applicableActive Not RecruitingNCT05669794
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World

Who this might be right for
Atopic Dermatitis
AbbVie 300
Large-scale testing (Phase 3)WithdrawnNCT04666675
What this trial is testing

Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Who this might be right for
Atopic Dermatitis (AD)
AbbVie
Testing effectiveness (Phase 2)Study completedNCT02525094
What this trial is testing

Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
MedImmune LLC 113
Testing effectiveness (Phase 2)Looking for participantsNCT07216027
What this trial is testing

Learn About Study Medicine Called PF-08049820 in People With Eczema

Who this might be right for
Atopic DermatitisEczema, Atopic
Pfizer 165
Large-scale testing (Phase 3)Study completedNCT05369403
What this trial is testing

Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 86
Testing effectiveness (Phase 2)Looking for participantsNCT06524635
What this trial is testing

Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Who this might be right for
Hidradenitis SuppurativaAtopic Dermatitis
AbbVie 60
Not applicableLooking for participantsNCT07444801
What this trial is testing

Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact

Who this might be right for
Atopic Dermatitis (Moderate-to-severe) Involving the Genital Region
University Hospital Schleswig-Holstein 30
Testing effectiveness (Phase 2)Study completedNCT04921345
What this trial is testing

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Galderma R&D 109
Large-scale testing (Phase 3)Not Yet RecruitingNCT06884891
What this trial is testing

A Phase Ⅲ Comparative Study of QL2108 to Dupixent®

Who this might be right for
Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd. 520
Large-scale testing (Phase 3)Study completedNCT05032859
What this trial is testing

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

Who this might be right for
Atopic Dermatitis
Organon and Co 406
Large-scale testing (Phase 3)Study completedNCT03661138
What this trial is testing

Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 272
Large-scale testing (Phase 3)Study completedNCT05375929
What this trial is testing

Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India

Who this might be right for
Atopic Dermatitis
Pfizer 200
Not applicableEnrolling By InvitationNCT06999941
What this trial is testing

A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features

Who this might be right for
PsoriasisEczemaJAK Inhibitor
Xi Tan 50
Large-scale testing (Phase 3)Study completedNCT04626297
What this trial is testing

Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 254
Testing effectiveness (Phase 2)Ended earlyNCT03831191
What this trial is testing

LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 136
Testing effectiveness (Phase 2)Active Not RecruitingNCT05769777
What this trial is testing

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 999
Testing effectiveness (Phase 2)Active Not RecruitingNCT07167758
What this trial is testing

A Study Evaluating TRIV-509 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Triveni Bio 95
Testing effectiveness (Phase 2)Study completedNCT06015308
What this trial is testing

Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

Who this might be right for
Dermatitis Atopic
Sanofi 224
Testing effectiveness (Phase 2)Looking for participantsNCT07217015
What this trial is testing

KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kymera Therapeutics, Inc. 200
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation